Peripheral vascular emergencies-clinicopathological co- relation with outcome in a tertiary care centre
DOI:
https://doi.org/10.18203/2349-2902.isj20233677Keywords:
Peripheral vascular disease, COVID-19, ALIAbstract
Background: Peripheral arterial disease represents a major caseload in emergency department and also is major cause of distress and socio-economic burden to patient and his/her family due to risk of complications. It has a multifactorial etilogy and requires prompt treatment to salvage the limb and prevent complications. This study is a clinic-pathological correlation between various factors and surgical outcome.
Methods: It is a prospective study involving 75 patients who had presented with peripheral vascular disease with different mode of presentations. All patients underwent surgical procedure and were given inj. heparin and tab. Aspirin in post operative period. Their surgical outcome was studied and co-related with etiological factors and clinical presentation.
Result: Time from onset till presentation was one of the most important factors in deciding outcome. COVID-19 also emerged as one of the important risk factors in 12 cases. Patients who had been given prior anticoagulation therapy had better outcomes.
Conclusions: Outcome in peripheral vascular disease patient depends on variable factors, however starting patients prior on anticoagulants has shown more possibility of salvaging the limb.
Metrics
References
Walker TG. Acute Limb Ischemia. Tech Vasc Interv Radiol. 2009;12(2):117-29.
Creager MA, Kaufman JA, Conte MS. Clinical practice. Acute Limb Ischemia. N Engl J Med. 2012;366(23):2198-206.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(S):S5-67.
Baril DT, Patel VI, Judelson DR, Goodney PP, McPhee JT, Hevelone ND et al. Vascular Study Group of New England. Outcomes of lower extremity bypass performed for acute limb ischemia. J Vasc Surg. 2013;58(4):949-56.
Eliason JL, Wainess RM, Proctor MC, Dimick JB, Cowan JA Jr, Upchurch GR et al A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann. Surg. 2003;238(3):382-9.
Debut B, Smadja DM. Is COVID-19 a new hematologic disease? Stem Cell Rev Rep. 2021;17(1):4-8.
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40
Varga Z, Flammer AJ, Steiger P, Martina H, Rea A, Annelies SZ et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8.
Klok FA, Kruip MJ, Van der Meer NJ, Arbous MS, Gommers DAMP, Kant KM et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7.
Wang W, Zhao T, Geng K, Yuan G, Xu Y. Smoking and the Pathophysiology of Peripheral Artery Disease. Front Cardiovasc Med. 2021;8:704106.
Nixon ME, Pinto KG, Kostalas MS, Williams DJ, Taylor JV. Anticoagulation in the Surgical Management do Peripheral Arterial Embolic Disease. J Vasc Endovasc Surg. 2017;2:31.
Downloads
Published
How to Cite
Issue
Section
